The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens-Reference-Cited by-同舟云学术

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

Published:1992-03 Issue:3-8 Volume:41 Page:665-669
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Veldscholte J.,Berrevoets C.A.,Ris-Stalpers C.,Kuiper G.G.J.M.,Jenster G.,Trapman J.,Brinkmann A.O.,Mulder E.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Androgen receptor binding regions of an androgem-responsive gene;Rushmere;Molec. Cell. Endocr.,1987

2. Functional characterization of an androgen response element in the 1st intron of the C3(1) gene of prostatic binding protein;Claessens;Biochem. Biophys. Res. Commun.,1989

3. Gene regulation by steroid hormones;Beato;Cell,1989

4. Regulation of prostatic steroid binding protein RNAs by testosterone;Zhang;Molec. Cell. Endocr.,1985

5. Androgen repressef messages in the rat ventral prostate;Montpetit;Prostate,1986

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into steroid hormone-mediated regulation of the androgen receptor gene;PLOS ONE;2024-08-01

2. An expanded metabolic pathway for androgen production by host-associated bacteria;2024-06-09

3. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer;PLOS ONE;2024-05-13

4. The association of HER-2 expression with clinicopathological characteristics and clinical outcomes in patients with localized prostate cancer after radical prostatectomy;2024-04-03

5. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer;2024-03-03